Atopic Dermatitis (Eczema) clinical trials at UC Davis
1 research study open to eligible people
open to eligible people ages 18 years and up
This open-label study will evaluate the long-term efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis (AD).
Sacramento, California and other locations